Abstract Hepatic fibrosis is one of the critical steps contained in the pathogenesis of liver cirrhosis. Excessive deposition of collagen contributes to the development of fibrosis in chronic liver injury. Activation of hepatic stellate cells (HSCs) plays an important role in fibrogenesis and is accountable for providing extracellular matrix components. The berry of Schisandra chinensis has been known to exert hepatoprotective properties. However, its effect on HSCs is not completely understood. Therefore, in this study, we investigated the inhibitory effect of its ethanolic extract (SBE) on hepatic fibrogenesis. We found that SBE treatment effectively reduced the serum levels of alanine aminotransferase and aspartate aminotransferase as well as collagen deposition in the hepatic parenchyma in a thioacetamide-induced hepatic fibrosis mouse model. Moreover, SBE inhibited transforming growth factor b (TGFb)-induced mRNA expression of a-smooth muscle actin (aSMA) and collagen type 1 a1 (COL1A1) in HSCs, suggesting that SBE exerts anti-fibrotic activity by attenuating TGFb-induced HSC activation. To identify the active components of SBE accountable for HSC inhibition, SBE was further partitioned based on the hydrophobicity of the solvents such as water, n-butanol, ethyl acetate, chloroform, and n-hexane. The n-hexane fraction was selected and further separated using analytical high-performance liquid chromatography. We found that six lignans contained in the n-hexane fraction strongly reduced TGFbinduced expression of both aSMA and COL1A1 mRNA. These data suggest that at least six lignans contained in SBE have the strong potential to prevent TGFb-induced HSC activation.
Introduction
The liver is the largest single organ in our body, is widely distributed over the right upper abdomen and left upper abdomen, and is known to be the most commonly damaged organ in both blunt and penetrating injuries. The liver is largely divided into the left liver and the right liver and is divided into 8 regions according to the running of the veins, arteries, and bile ducts. The liver is divided into the arterial and portal vein. The blood vessels are very abundant in the receiving organs, and a large amount of bleeding may occur when they are damaged. In addition, secondary damage of the bile ducts in the liver may be accompanied by stomach, duodenum, pancreas, and adrenal glands surrounding the liver. The liver is an important organ that plays a pivotal role in the detoxification of metabolism and various endogenous and exogenous harmful substances. However, hepatocytes are destroyed, liver function is less than half, and special symptoms do not appear. Because many drugs are metabolized through the liver, if we take the drug over a liver function, we may develop a herd that can cause liver dysfunction. Hepatocyte damage refers to necrosis of hepatocytes, fatty hepatitis or cognitive vaginosis. It can be caused by various drugs including tetracycline, ritonavir, risperidone, phenytoin, valproate, nevirapine, ketoconazole, pyrazinamide, rifampin, trazodone, halothane, aspirin, diclofenac, and acetaminophen. If hepatocyte damage persists for a long time, hepatic fibrosis accumulates in the liver. Hepatic fibrosis is an inflammatory response to liver injury, characterized by excessive accumulation of extracellular matrix (ECM) proteins in the hepatic parenchyma [1] . When hepatocytes are damaged by various stimuli, such as inflammation, alcohol poisoning, or toxic drugs, infiltrating inflammatory lymphocytes and resident liver macrophages (Kupffer cells) release various growth factors, including transforming growth factor-b (TGFb), platelet-derived growth factor, and tumor necrosis factor-a. Hepatic stellate cells (HSCs), also known as Ito cells or lipocytes, are star-like-shaped cells located between hepatocytes and sinusoidal endothelial cells. HSCs represent 5-8% of all liver cells and play a role in the uptake and storage of vitamin A [2] . HSCs are activated by these growth factors and play a critical role in promoting tissue regeneration by producing collagen-rich ECM proteins [3] . However, when hepatocyte destruction and regeneration occur repeatedly, massively accumulated collagens are transformed from fine fibrils to thick fibers, leading to the development of hepatic fibrosis [4] . Advanced hepatic fibrosis disrupts the hepatic architecture and eventually causes liver cirrhosis and dysfunction [1] . As fibrosis is a reversible reaction [5] , it has been suggested that the prevention or treatment of hepatic fibrosis can be achieved by blocking the synthesis of collagen fibers. Therefore, it is important to inhibit the activity of HSCs to prevent the progression of hepatic fibrosis [3] . Unfortunately, there is no good way to treat hepatic fibrosis.
Schisandra chinensis is a medicinal herb that belongs to the Schisandraceae family, whose growth range extends from northeast China, Korea, and Japan to the most eastern part of Russia [6, 7] . Because it tastes sour, sweet, spicy, bitter, and salty, it is called omiza in Korea. The berry of S. chinensis is widely used in traditional Chinese, Japanese, Russian, and Korean medicine [7] . One of Korean traditional medical books, Donguibogam reports the berry of S. chinensis can restore fatigue, strengthen heart function, improve blood circulation, and prevent memory loss or slowing of thinking ability. The berry of S. chinensis contains various active compounds and exerts a wide range of biological activities, including antioxidant, anti-inflammatory, antimicrobial, anti-allergic, anti-tumor, anti-angiogenic, antiseptic, and anti-hepatotoxic effects, and protective effects against cardiovascular disease and on pancreatic b-cells in diabetic rats and on oxidative stress and cytotoxic activities. [7] . Many studies have reported that dibenzocyclooctadiene lignans, such as schisandrin A (deoxyschisandrin), schisandrin B (gomicin N), gomisin A (schisandrol B), and gomisin J, have protective effects against liver injury [8] [9] [10] [11] [12] 
00 -O-(4-hydroxycinnamoyl)-astragalin have been identified as the components of S. chinensis.
However, the effect of the berry of S. chinensis on inhibiting HSCs has not been well characterized. In this study, we aimed to determine the anti-HSC effect of the ethanolic extracts of the berry of S. chinensis (named as SBE) against TGFb-stimulated HSCs and identify the bioactive ingredient in SBE responsible for inhibiting TGFb-induced a-smooth muscle actin (aSMA) and collagen type 1 a1 (COL1A1) expression.
Materials and methods

Chemicals and reagents
Thioacetamide was obtained from Sigma-Aldrich (St. Louis, MO, USA). TGFb was purchased from R&D Systems (Minneapolis, MN, USA). Lignans including gomisin D, gomisin G, gomisin H, gomisin J, gomisin N, gomisin O, angeloylgomisin H, angeloylgomisin O, and benzoylgomisin O were purchased from Biopurify (Chengdu, Sichuan, China). Other chemicals were purchased from Sigma-Aldrich.
Preparation of Schisandra extracts
The berry of S. chinensis was collected from Mungyeong Miso farm (Gyeongbuk, Korea) in September 2016, and a voucher herbarium specimen was deposited at Konkuk University, Korea. The berry was dried under a shaded lot, and the dried berry (9000 g) was extracted three times with ethanol for three days. The ethanolic extract (2747.51 g, 30.53%) was subjected to sequential separation with solvents of different polarities. Five fractions were obtained: n-hexane (3.35%), chloroform (0.67%), ethyl acetate (11.12%), n-butanol (59.37%), and aqueous fraction (22.99%). Whole fractions were freeze-dried and stored at -20°C until further experiments. Analytical high-performance liquid chromatography (HPLC) was performed to analyze the components in SBE. The method of the analytical HPLC for the identification of the components followed the procedure provided by the manufacture.
Induction of hepatic fibrosis with thioacetamide in Balb/c mice
Balb/c mice were purchased from Youngbio (Seongnam, Gyeonggi-do, Korea). Mice were divided into 3 groups (n = 3/group): control, TAA only, and TAA with SBE ( Fig. 1A) . Control group mice were intraperitoneally administered phosphate-buffered saline (PBS) solution. Hepatic fibrosis was induced by intraperitoneal injection of TAA (100 mg/kg) three times per week for a total of 8 weeks. SBE (300 mg/kg) was orally administered once per day for 10 days before TAA treatment, and then TAA and SBE were administered on the same schedule (Fig. 1A) . After 8 weeks of TAA treatment, liver and blood samples were collected. Animal experiments were approved by the Committee of Laboratory Animals of Konkuk University (IACUC No. KU16187).
Analysis of mouse liver function
Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined by measuring enzyme activities with a commercial assay kit using a Mindray BS400 automated spectrophotometer according to the manufacturer's instructions (Mindray Medical International Ltd., Shenzhen, China).
Collagen staining in the mouse liver tissues
Mouse liver tissues were fixed with 10% neutral formalin and embedded in paraffin. The paraffin sections were stained with hematoxylin and eosin (H&E). Histological visualization of collagenous connective tissues was stained with a Trichrome Staining kit (ab150686 Connective Tissue stain; Abcam, Cambridge, UK) and collagen I and III fibers were stained with a Picro Sirius Red Staining Kit (ab150681 Connective Tissue stain; Abcam) according to the manufacturer's instructions.
Cell line and cell culture
HSCs were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in DMEM containing 10% fetal bovine serum (Invitrogen Life Technologies, Carlsbad, CA, USA) and antibioticanti-mycotic solution (Invitrogen Life Technologies) at 37°C in a 5% CO 2 incubator. 
Quantitative real time-PCR (Q-PCR)
The relative expression levels of aSMA and GAPDH mRNAs were measured with a TaqMan-iQ TM supermix kit (Bio-Rad) using the Bio-Rad iCycler iQ TM according to the manufacturer's instructions. TaqMan TM fluorogenic probes and PCR probes were synthesized by Metabion International (Martinsried, Germany) as follows: COL1A1 TaqMan probe, 5
0 (FAM, 6-carboxyfluorescein; BHQ, tert-butylhydroquinone; YY, Yakima Yellow). Expression values were normalized to that of GAPDH mRNA in the same samples using the software program provided by the manufacturer.
Statistical analysis
Statistical significance was determined by one-way analysis of variance followed by Sidak's multiple comparisons test using GraphPad Prism version 7.02 (GraphPad Software, Inc., La Jolla, CA, USA).
Results and discussion
Effect of Schisandra berry ethanolic extract (SBE) on TAA-induced liver injury When liver cells are damaged, liver ALT and AST enzymes are released into the blood. Therefore, increases in plasma ALT and AST levels are commonly used as a key biochemical marker for hepatotoxicity. Thioacetamide (TAA) is a hepatotoxin that causes acute hepatic failure in exposed animals [13] . To test the potential of SBE in protecting against liver injury, mice were divided into three groups and treated with vehicle, TAA, or TAA in combination with SBE for 8 weeks: G1, vehicle only; G2, TAA alone; and G3, SBE for 10 days, followed by SBE plus TAA (Fig. 1A) . Treatment with TAA alone (3 times/week for 8 weeks; G2 group) significantly elevated the serum levels of ALT (Fig. 1B) and AST (Fig. 1C) compared to those in the control G1 group, indicating that TAA causes hepatotoxicity under our experimental conditions. However, in the presence of SBE, TAA-induced ALT and AST activities were significantly (all P \ 0.05 by Sidak's multiple comparison test) reduced compared to those in the TAA-treated G2 group. These data suggest that SBE may have a beneficial effect against acute TAA-induced hepatotoxicity.
SBE ameliorates TAA-induced hepatic fibrosis
In TAA-treated livers, morphological features of parenchymal cells and lobular architectures were severely altered compared to those of the vehicle-treated control, whereas in the SBE-administered group, liver damage by TAA remarkably improved ( Fig. 2A) . It has been demonstrated that TAA-induced liver injury causes hepatic fibrosis [14] . The most characteristic feature of hepatic fibrosis is excessive deposition of extracellular matrix proteins, particularly collagen fibers. To determine the effect of SBE on the protection of hepatic fibrosis, collagen accumulation was visualized by modified Masson's trichrome staining (blue staining; Fig. 2B ) and Picro Sirius Red staining (red staining; Fig. 2C ). In TAA-treated hepatic tissue, severe deposition of collagen was observed.
However, TAA-induced collagen fibers were substantially decreased in SBE-treated liver tissue. These data suggest that SBE inhibits the deposition of collagen fibers induced by TAA in the mouse liver.
TGFb increases aSMA and COL1A1 expression in HSCs
HSCs play a crucial role in the production of collagens in response to liver injury [3] . HSCs are in the perisinusoidal space between sinusoid endothelial cells and hepatocytes. TGFb, which is secreted from injured hepatocytes and Kupffer cells, triggers activation of quiescent HSCs into myofibroblast-like cells [15] . Activated HSCs expressing aSMA enhance the synthesis of matrix proteins, including COL1A1, and promote hepatic fibrosis [16] . To assess the effect of TGFb on HSC activation, we examined the expression of aSMA and COL1A1 mRNAs by reverse transcription-polymerase chain reaction (RT-PCR). Following TGFb stimulation, the aSMA mRNA level increased within 6 h and was sustained for at least 12 h and COL1A1 expression gradually increased for up to 24 h after treatment (Fig. 3A) . Q-PCR showed that aSMA mRNA levels increased by 4.6 ± 0.56-, 5.3 ± 0.32-, and (A) HSCs were either untreated or treated with 50 or 100 lg/mL SBE for 30 min, followed by stimulation with 10 ng/mL TGFb. After 12 h, total RNA was isolated and aSMA and COL1A1 mRNA expression was measured by RT-PCR. Actin mRNA level was used as an internal control. (B, C) HSCs were treated as in (A), and total RNA was isolated. aSMA (B) and COL1A1 (C) mRNA expression was measured by Q-PCR. The relative fold changes were normalized to GAPDH mRNA. Data are presented as the mean ± SD (n = 3). ** P = 0.002; *** P \ 0.001 by ANOVA followed by Dunnett's multiple comparisons test. (D) HSCs were either untreated or treated with 20, 50 or 100 lg/mL SBE for 30 min, followed by stimulation with 10 ng/mL TGFb. After 12 h, whole cell lysates were prepared and immunoblot analysis was performed with antibody against COL1A1. GAPDH level was measured as an internal control 2.3 ± 0.38-fold (all P \ 0.01) (Fig. 3B) , whereas COL1A1 mRNA levels were increased by 2.7 ± 0.20-, 3.67 ± 0.21-, and 4.2 ± 0.30-fold (all P \ 0.001) (Fig. 3C) , respectively, after 6, 12, and 24 h of TGFb stimulation. TGFb-induced elevation of COL1A1 protein levels was confirmed by immunoblotting (Fig. 3D ). These data demonstrate that TGFb stimulates HSCs in a timedependent manner under our experimental conditions.
SBE inhibits TGFb-induced activation of hepatic stellate cells
We next investigated whether SBE can inhibit HSCs stimulated by TGFb. HSCs were pre-treated with 50 and 100 lg/mL SBE before the addition of TGFb. RT-PCR showed that TGFb-induced aSMA and COL1A1 expression was considerably attenuated in the presence of SBE (Fig. 4A) . To precisely quantify the inhibitory activity of SBE on TGFb-induced HSC activation, Q-PCR analysis was performed. Expression levels of aSMA (Fig. 4B) and COL1A1 (Fig. 4C ) mRNAs were increased by 4.2 ± 0.70-and 3.5 ± 0.35-fold (all P \ 0.001), respectively, compared to those of the control group by TGFb stimulation. SBE treatment attenuated these TGFb inducibilities of both aSMA and COL1A1 mRNAs in a dose-dependent manner. Inhibitory effect of SBE on TGFb-induced COL1A1 expression was confirmed by immunoblotting (Fig. 4D) . These results suggest that SBE inhibits TGFb-induced HSC activation. Identification of functional components of SBE responsible for suppression of TGFb-induced activation of HSCs
To identify the functional components of SBE that inhibit HSCs, SBE was further partitioned successively with nhexane, chloroform, ethyl acetate, n-butanol, and water. HSCs were treated with each fraction before TGFb stimulation, and then aSMA mRNA levels were measured by RT-PCR. We found that the n-hexane and n-butanol fractions of SBE had strong inhibitory effects on TGFb-induced aSMA expression (Fig. 5A) . We chose the n-hexane (B) HSCs were either untreated or treated with 100 lg/mL solvent extracts for 30 min, followed by stimulation with 10 ng/mL TGFb. After 12 h, total RNA was isolated and aSMA and COL1A1 mRNA expression was measured by RT-PCR. Actin mRNA level was used as an internal control benzoylgomisin O were observed in the chromatogram of the n-hexane fraction (Fig. 5B, top) . Although many studies have reported the hepatoprotective effects of lignan compounds isolated from S. chinensis, little information is available regarding the inhibitory effect on HSCs.
To determine whether lignan components exhibit inhibitory activity on TGFb-stimulated HSCs, we used commercially available lignans (Fig. 6A ). HSCs were treated with different lignans before stimulation with TGFb, and aSMA and COL1A1 mRNA levels were measured. RT-PCR revealed that six lignans (gomicin G, gomicin O, gomisin J, gomicin N, angeloylgomisin H, and benzoylgomisin O) reduced TGFb-induced expression of both aSMA and COL1A1 mRNA (Fig. 6B) . These data suggest that at least six lignans in SBE have the potential to prevent TGFb-induced activation of HSCs.
HSCs are primary cells that produce type-I collagen, a predominant extracellular matrix protein in liver fibrosis [17] . TGFb is the most potent factor in promoting liver fibrosis by expressing extracellular matrix proteins [16, 18] . During hepatic injury, TGFb is secreted from hepatocytes, platelets, Kupffer cells, and sinusoidal endothelial cells [19] . It activates HSCs and then stimulates Smad2 and Smad3 transcription factors that regulate transcription of various target-genes including COL1A1 [20] . Type-I collagen is composed of the a1 and a2 chains encoded by the COL1A1 and COL1A2 genes, respectively [21] . The previous study has reported that overexpression of Smad3 is sufficient to express COL1A1, suggesting that Smad transcription factors are essential in TGFb-induced COL1A1 expression.
Previously, Park et al. [22] have demonstrated that p38 and JNK mitogen-activated protein kinase (MAPK) pathways stimulate Smad2/3 and gomicin N (also called schisandrin B) protects TGFb-induced vascular fibrosis through inhibition of p38 and JNK MAPKs in rat aortic smooth muscle cell. Also, Chen et al. [12] have reported that gomicin N protects carbon tetrachloride (CCL 4 )-induced liver fibrosis by inhibition of TGFb-mediated Smad signaling pathway. Similarly, it is possible that SBE inhibits TGFb-induced COL1A1 expression through inhibition of Smad signaling pathway. Oxidative stress is closely associated with liver fibrosis [23] . Indeed, TGFb-induced oxidative stress up-regulates COL1A1 gene expression via the activation of a CCAAT/enhancer binding protein-b (C/ EBPb) [24] . It has been reported that gomisin A and gomicin N inhibit ROS production in lipopolysaccharidetreated microglial cells [25] and doxorubicin-treated mouse heart [26] . Thus, it is also possible that lignans in SBE may abrogate TGFb-induced COL1A1 expression through reducing of ROS accumulation in HSCs. Whether each lignan targets the same signaling pathway warrants further investigation. Future studies should explore which signaling pathway is responsible for mediating the inhibitory effect of each lignan on COL1A1 expression in HSCs.
In summary, this study showed that SBE inhibits TGFbinduced aSMA and COL1A1 mRNA expression in HSCs. We also found that at least six lignans (gomicin G, gomicin O, gomicin N, gomisin J, angeloylgomisin H, and benzoylgomisin O) in the n-hexane fraction of the SBE were functionally involved in inhibiting TGFb-induced HSC activation. Given that activation of HSCs plays a critical role in hepatic fibrogenesis in the injured liver, SBE can be utilized as a functional ingredient for preventing hepatic fibrosis.
